Discontinuation of anticoagulation therapy in patients who have experienced an acute intramuscular bleed and are also at risk for a stroke

Am J Phys Med Rehabil. 2014 Oct;93(10):925-6. doi: 10.1097/PHM.0b013e3182922bcb.
No abstract available

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anticoagulants / adverse effects*
  • Anticoagulants / therapeutic use
  • Atrial Fibrillation / diagnosis
  • Atrial Fibrillation / drug therapy
  • Disease Susceptibility / etiology
  • Disease Susceptibility / physiopathology
  • Female
  • Follow-Up Studies
  • Hemorrhage / chemically induced*
  • Hemorrhage / physiopathology
  • Humans
  • Male
  • Musculoskeletal Diseases / chemically induced*
  • Musculoskeletal Diseases / physiopathology
  • Risk Assessment
  • Sampling Studies
  • Stroke / etiology*
  • Stroke / physiopathology
  • Warfarin / adverse effects*
  • Warfarin / therapeutic use
  • Withholding Treatment*

Substances

  • Anticoagulants
  • Warfarin